Versiti Blood Research Institute Articles
Search / Filter By:
Sort By:
Addressing a major cause of vision loss globally
December 05, 2024
Through her research, Dr. Chrzanowska aims to understand the roles and functions of RAP1B in the regulation of signaling by VEGF, and inflammatory factors and their impact on the vasculature of the retina.
Creating the blood products of the future
December 02, 2024
Genetically engineered transfusable platelets could be used to improve blood banking and treat patients with cancer, pulmonary embolism and deep vein thrombosis.
Using genome editing to treat sickle cell disease
December 02, 2024
Genome editing targets SCD’s root cause through precise genetic intervention.
Using AI to better predict, diagnose and treat cancer
October 22, 2024
Bioinformatics data will help investigators understand what causes cancer to develop and how to treat it.
Versiti Blood Research Institute graduate students awarded prestigious Chateaubriand Fellowship
August 02, 2024
Emily Boyd and Mindy Kim will conduct research at institutions in France that partner with laboratories at VBRI.
Versiti participates in successful clinical trial for new treatment for children with hemophilia A
July 18, 2024
Versiti Comprehensive Center for Bleeding Disorders, led by Lynn Malec, MD, MSc, had the highest enrollment in this groundbreaking clinical trial.
Understanding the Role of the Liver in Sickle Cell Disease
February 23, 2024
Associate Investigator Tirthadipa Pradhan-Sundd, PhD, studies the mechanisms behind hematological diseases and how to improve patient outcomes.
Versiti Blood Research Institute to develop hematology biorepository
January 24, 2024
The biobank will serve as a resource for advancing research and will bridge the gap between basic research and clinical applications.
Paving the Way For New Sickle Cell Disease Treatments
December 14, 2023
Versiti Blood Research Institute (VBRI) Senior Investigator Prithu Sundd, PhD, is interested in exploring how two types of cells—neutrophils and platelets—contribute to thrombosis and inflammation (thrombo-inflammation) in SCD.
Addressing the Healthcare Challenges and Disparities Among Sickle Cell Disease Patients
December 14, 2023
Dr. Sundd’s aim is to improve education surrounding blood donation in diverse communities and develop new SCD therapies that tackle the disease head-on.